Jane Street
RAPP

Jane Street’s Rapport Therapeutics RAPP Stock Holding History

Jane Street’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+5,000
New +$184K ﹤0.01% 10051
2025
Q4 		– Sell
-51,100
Closed -$1.52M – 12664
2025
Q3 		$1.52M Buy
+51,100
New +$912K ﹤0.01% 5449

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jane Street's RAPP Position: Q2 2026 in Review

Jane Street opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 55,705 shares worth $2.32M. The stake represents ﹤0.01% of the portfolio and ranks #4910 among its holdings. This is a return to the name: Jane Street previously reported a position in RAPP as recently as Q3 2025.

Jane Street first reported a position in RAPP in Q3 2025 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Jane Street held 55,705 shares of Rapport Therapeutics worth $2.32M as of Q2 2026.
  • Rapport Therapeutics was a new Jane Street position in Q2 2026.
  • Rapport Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4910 holding.
  • Jane Street first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.